Market Survey on Atrial Appendage Occluder Market Covering Sales Outlook, Up-to-date Key Trends, Market Size and Forecast, Per Capita Expenditure, Company Share, Brand Share, Regulations, Reimbursement Scenario, Epidemiology, Procedure Numbers, and Pipeline Assessment
An In-depth Market Insights of Atrial Appendage Occluder Market including Non-valvular Atrial Fibrillation Covering 30+ Countries like United States, United Kingdom, Germany, France, Norway, Sweden, Saudi Arabia, United Arab Emirates, Japan, Korea, Australia, New Zealand, and Others
Atrial Appendage Occluder Market Outlook (2023 to 2033)
The atrial appendage occluder market size is projected to be valued at US$ 983.5 million in 2023 and is expected to rise to US$ 8193.0 million by 2033. The sales of atrial appendage occluders are projected to expand at a significant CAGR of 23.6% during the forecast period.
The atrial appendage, better described as the left atrial appendage (LAA) is an ear-shaped pouch present in the top left chamber of the human heart (Left Atrium). The functional significance of this structure is unknown. In patients living with arrhythmic cardiovascular conditions such as atrial fibrillation, blood accumulates in the left atrial appendage and can cause clotting of blood.
The blood clots can cause fatal strokes when pumped into the blood vessels. Along with oral anticoagulants, occlusion of LAA by an occluder is an alternative approach to protect cardiovascular patients from strokes and other complications. An atrial appendage occluder is thus a kind of plug that permanently closes the appendage.
According to a study published in the journal, Clinical Medical Insights, Cardiology, atrial fibrillation affects around 2 percent of the global population and the prevalence of the disease is expected to increase five times over the next four decades, especially in the United States, owing to the expanding elderly population base.
Customize your report by selecting specific countries or regions and save 30%!
Atrial Appendage Occluder Market Demand Analysis (2018 to 2022) Vs Market Outlook (2023 to 2033)
The global demand for atrial appendage occluders is projected to rise at a CAGR of 23.6% during the forecast period between 2023 and 2033, reaching a total of US$ 8193.0 million in 2033, according to a report from Future Market Insights (FMI). From 2018 to 2022, sales witnessed significant growth, registering a CAGR of 8.5%.
The increasing number of cardiovascular patients suffering from atrial fibrillation and thromboembolism is the primary factor contributing to market growth. Further, people's changing lifestyles, as well as the growing number of people suffering from obesity, diabetes, and hypertension, are increasing demand for the devices, contributing to market growth.
In the upcoming years, atrial appendage occluder market systems are expected to gain prominence as many new construction sites are already installing the same as a necessity. With the construction industry developing significantly in emerging regions, the demand for the Atrial appendage occluder market is expected to rise.
Certain factors, such as the limited use of the LAA occluder for patients who have a high risk of bleeding as well as stroke while on anticoagulant therapy, are limiting the market's growth. A few more factors limiting market growth include unfavorable policies and complications associated with surgery.
Which Are Some Prominent Drivers of the Atrial Appendage Occluder Market?
Growing Number of Cardiovascular Patients to Push Sales
The surging number of cardiovascular patients diagnosed with thromboembolism and atrial fibrillation worldwide is a key driver to the growth of the global atrial appendage occluder market. In addition, sedentary lifestyles and ailments like diabetes, obesity, and hypertension are also going to drive demand for such devices, paving the way for market expansion.
The global atrial appendage occluder market is extremely concentrated, with only a few players. Annually, roughly 15 million strokes occur worldwide, according to the World Health Organization (WHO). In 2010, the United States spent around US$ 53.9 billion on health care services, and drugs, and lost work days due to a heart stroke.
Ischemic strokes account for almost 87% of all strokes, which occur when blood circulation to the brain is compromised. Stroke is third among the main causes of mortality, and it is also the leading cause of long-term disability. Around 20% of ischemic strokes are caused by atrial fibrillation. All of these factors are catalyzing the growth of the atrial occluder market.
Find your sweet spots for generating winning opportunities in this market.
What are the Challenges Faced by the Atrial Appendage Occluder Market?
Restricted Use of LAA Occluder to Stifle the Market Growth
The restricted use of LAA occluder solely for those at high risk of stroke and bleeding while on anticoagulant medication may limit market expansion. Furthermore, difficulties associated with device implantation and removal, such as tissue erosion, which might necessitate open heart surgery, may function as a limiting factor for market expansion. Also, unfavorable policies concerning endocardial LAA closure are likely to hamper market expansion.
Comparative View of the Atrial Appendage Occluder Market
Atrial Appendage Occluder Market
Attributes
Atrial Appendage Occluder Market
CAGR (2023 to 2033)
23.6%
Market Value (2033)
US$ 8193.0 million
Growth Factor
The surging number of cardiovascular patients diagnosed with thromboembolism and atrial fibrillation worldwide is a key driver to the growth of the global atrial appendage occluder market.
Opportunity
Sedentary lifestyles and ailments like diabetes, obesity, and hypertension are likely to drive demand for such devices, paving the way for market expansion.
Key Trends
The demand for the atrial appendage occluder market is expected to rise due to the construction industry developing significantly in emerging regions.
Amblyopia Treatment Market
Attributes
Amblyopia Treatment Market
CAGR (2023 to 2033)
3.8%
Market Value (2033)
US$ 5,582.3 million
Growth Factor
The growing prevalence of hypermetropia and myopia across the globe is expected to play a key role in driving the market during the forecast period.
Opportunity
Players are adopting various innovative methods to advance the treatment method which is projected to offer remunerative opportunities to the industry in the forthcoming time.
Key Trends
Increasing focus on technological development for advanced products in the amblyopia treatment market is likely to offer significant opportunities to the market in the forthcoming period.
Osteonecrosis Treatment Market
Attributes
Osteonecrosis Treatment Market
CAGR (2023 to 2033)
4.9%
Market Value (2033)
US$ 434.0 million
Growth Factor
The increasing geriatric population is leading to a rise in hip injuries and this is promoting the market during the forecast period.
Opportunity
The market opportunities might surge owing to several research and development activities for developing novel drugs.
Key Trends
The demand is said to escalate due to rising awareness about non-invasive methods of osteonecrosis treatment.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need and save 40%!
Category-wise Insights of Atrial Appendage Occluder
Which Procedure of Positioning the Device is Leading in the Global Atrial Appendage Occluder Market?
The Endocardial Segment is to have the Highest Demand
The endocardial segment is anticipated to have a high market share of 87.20% because they are both safe and effective. Further, several clinical studies on endocardial devices have yielded encouraging results for the patient population in terms of stroke risk reduction, contributing to the segment's market share.
The endocardial segment is likely to have a low complication rate (around 8.5%) than the Epicardial (25.4%), which is believed to drive segment growth. In addition, Epicardial has emerged as an alternative procedure for LAA closures to improve efficacy, especially in patients who have had poor results with the standard endocardial technique.
The Epicardial segment is forecasted to account for 15% of the global atrial appendage occluder market share during the forecast period.
Which End-Use Segment is Likely to Contribute Most to the Global Atrial Appendage Occluder Market?
Hospital Segment to be the Dominant Segment Acquiring 63.20% Value Share
The hospital segment of the atrial appendage occluder market is anticipated to expand notably. The growing number of hospitals and the advancement of infrastructure are expected to drive demand for the devices.
According to the Centres for Medicare and Medicaid Services, the United States spent almost 3.6 trillion US$ on healthcare management in 2018. This is expected to boost the market for atrial appendage occluder. Furthermore, the rising prevalence of atrial fibrillation is expected to play a significant role in this segment. Atrial fibrillation is one of the most common heart conditions, according to the European Society of Cardiology.
The prevalence of atrial fibrillation in people aged 65 and older was around 7.6 million in 2016, and it is expected to rise by 89%, to around 14 million by 2060. Hence, the aforementioned factors are expected to increase hospital visits for atrial appendage management, increasing demand for atrial appendage occluder in this segment.
Regional Analysis of the Atrial Appendage Occluder Market
A Growing Geriatric Population Driving Demand for Atrial Appendage Occluders in North America?
As per FMI, North America is anticipated to dominate the atrial appendage occluders market during the forecast period. This is because of its vast geriatric population. Moreover, the region's huge population, which accounts for the high number of stroke deaths, is the primary cause for individuals depending on atrial appendage occluders, particularly in the United States. Thus, in 2022, North America held a market share of 39.8% for atrial appendage occluder.
Is the Increased Risk of Atrial Fibrillation Fueling Europe’s Market for Atrial Appendage Occluders?
According to a report published in the journal Indian Pacing and Electrophysiology Journal, Europe’s Atrial appendage occluder market is likely to rise since more than 6 million people in Europe are already living with arrhythmia, and the number is expected to double over the next 50 years. According to one study, the European race has a great incidence of atrial fibrillation than other races.
Sedentary lifestyles and the number of persons with cardiovascular problems are predicted to rise in developed nations, driving market development in the future. This, in turn, is projected to serve the atrial appendage occluder market development. As a result of the aforementioned factors, Europe held a market share of 27.3% in the atrial occluder market in 2022.
Competitive Landscape
Key players in the atrial appendage occluder market include Appriva Medical Inc., Boston Scientific, Abbott, SentreHEART Inc, and pfm Medical Ag. Occlutech, W. L. Gore & Associates, Coherex Medical, Inc., Cardia, Inc., and AtriCure, Inc. amongst others.
Key players focus on strategic formulations such as research collaborations, new product releases, market penetration, and distribution alliances for developing a commercial presence. Furthermore, these industry leaders are substantially spending on research activities, which encourage innovation and help them to commercialize improved products and maximize market income.
Recent Developments in the Atrial Appendage Occluder Market
In August 2022, Abbott and WW International, Inc. established a strategic alliance to assist people with diabetes to better understand and manage their diabetes and weight. The companies are collaborating to integrate WeightWatchers' diabetes-specific weight management program with Abbott's portfolio of FreeStyle Libre® products to create a seamless mobile experience that is going to provide people living with diabetes with information and insights.
Diabetic people can make healthy dietary adjustments, improve their glucose levels, and, ultimately, gain more control of their health through the information and insights provided.
In July 2022, DURAMESH Suturable Mesh is being added to the product portfolio of PFM Medical AG. For the first time. This novel suturable mesh combines the benefits of mesh repair with the precise application of surgical sutures. When large pressures must be imparted, DURAMESH can be used in place of surgical sutures.
In June 2022, Boston Scientific Corporation, announced that it has entered into a definitive agreement with Synergy Innovation Co., Ltd to acquire its majority stake in M.I.Tech Co., Ltd, a publicly traded Korean manufacturer and distributor of medical devices for endoscopic and urologic procedures. M.I.Tech invented the HANAROSTENTTM technology, a line of conformable, non-vascular, self-expanding metal stents supplied in Japan by Boston Scientific since 2015. The acquisition price is KRW 14,500 per share, for a total of KRW 291.2 billion, or roughly US$ 230 million at current exchange rates, subject to closing adjustments.
Scope of the Report
Attribute
Details
Growth Rate
CAGR of 23.6% from 2023 to 2033
Base Year of Estimation
2023
Historical Data
2018 to 2022
Forecast Period
2023 to 2033
Quantitative Units
Revenue in US$ billion and Volume in Units and F-CAGR from 2022-2032
Report Coverage
Revenue Forecast, Volume Forecast, Company Ranking, Competitive Landscape, growth factors, Trends, and Pricing Analysis
Key Segments Covered
Type of Indication
Positioning of Device
End User
By Region
Regions Covered
North America
Latin America
Europe
East Asia
South Asia
The Middle East & Africa
Oceania
Key Countries Profiled
The United States
Canada
Brazil
Mexico
Germany
Italy
France
The United Kingdom
Spain
Russia
China
Japan
India
GCC Countries
Australia
Key Companies Profiled
Appriva Medical Inc.
Boston Scientific
Abbott
SentreHEART Inc
pfm medical ag.
Occlutech
W. L. Gore & Associates
Coherex Medical, Inc.
Cardia, Inc.
AtriCure, Inc.
Customization & Pricing
Available upon Request
Key Segments Covered in the Atrial Appendage Occluder Market Report
By Type of indication:
Non-valvular Atrial Fibrillation
The Procedure of Positioning of the Device:
Endocardial
Epicardial
By End-user:
Hospitals
Clinics
By Region
North America
Latin America
Western Europe
Eastern Europe
Asia Pacific Excluding Japan (APEJ)
Japan
The Middle East & Africa (MEA)
Frequently Asked Questions
The global atrial appendage occluder market is estimated to be valued at US$ 983.5 million in 2023.
The atrial appendage occluder market is likely to thrive at a CAGR of 23.6% from 2023 to 2033.
The atrial appendage occluder market is projected to reach a valuation of US$ 8193.0 million by 2033.
North America is projected to lead the global atrial appendage occluder market by 2033.
Table of Content
1. Executive Summary
1.1. Global Market Outlook
1.2. Demand-side Trends
1.3. Supply-side Trends
1.4. Technology Roadmap Analysis
1.5. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
3. Market Background
3.1. Market Dynamics
3.1.1. Drivers
3.1.2. Restraints
3.1.3. Opportunity
3.1.4. Trends
3.2. Scenario Forecast
3.2.1. Demand in Optimistic Scenario
3.2.2. Demand in Likely Scenario
3.2.3. Demand in Conservative Scenario
3.3. Opportunity Map Analysis
3.4. Investment Feasibility Matrix
3.5. PESTLE and Porter’s Analysis
3.6. Regulatory Landscape
3.6.1. By Key Regions
3.6.2. By Key Countries
3.7. Regional Parent Market Outlook
4. Global Analysis 2018 to 2022 and Forecast, 2023 to 2033
4.1. Historical Market Size Value (US$ Million) Analysis, 2018 to 2022
4.2. Current and Future Market Size Value (US$ Million) Projections, 2023 to 2033
4.2.1. Y-o-Y Growth Trend Analysis
4.2.2. Absolute $ Opportunity Analysis
5. Global Analysis 2018 to 2022 and Forecast 2023 to 2033, By Type of indication
5.1. Introduction / Key Findings
5.2. Historical Market Size Value (US$ Million) Analysis By Type of indication, 2018 to 2022
5.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Type of indication, 2023 to 2033
5.3.1. Non-valvular Atrial Fibrillation
5.4. Y-o-Y Growth Trend Analysis By Type of indication, 2018 to 2022
5.5. Absolute $ Opportunity Analysis By Type of indication, 2023 to 2033
6. Global Analysis 2018 to 2022 and Forecast 2023 to 2033, By Procedure of positioning of the device
6.1. Introduction / Key Findings
6.2. Historical Market Size Value (US$ Million) Analysis By Procedure of positioning of the device, 2018 to 2022
6.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Procedure of positioning of the device, 2023 to 2033
6.3.1. Endocardial
6.3.2. Epicardial
6.4. Y-o-Y Growth Trend Analysis By Procedure of positioning of the device, 2018 to 2022
6.5. Absolute $ Opportunity Analysis By Procedure of positioning of the device, 2023 to 2033
7. Global Analysis 2018 to 2022 and Forecast 2023 to 2033, By End user
7.1. Introduction / Key Findings
7.2. Historical Market Size Value (US$ Million) Analysis By End user , 2018 to 2022
7.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By End user , 2023 to 2033
7.3.1. Hospitals
7.3.2. Clinics
7.4. Y-o-Y Growth Trend Analysis By End user , 2018 to 2022
7.5. Absolute $ Opportunity Analysis By End user , 2023 to 2033
8. Global Analysis 2018 to 2022 and Forecast 2023 to 2033, By Region
8.1. Introduction
8.2. Historical Market Size Value (US$ Million) Analysis By Region, 2018 to 2022
8.3. Current Market Size Value (US$ Million) Analysis and Forecast By Region, 2023 to 2033
8.3.1. North America
8.3.2. Latin America
8.3.3. Western Europe
8.3.4. Eastern Europe
8.3.5. South Asia and Pacific
8.3.6. East Asia
8.3.7. Middle East and Africa
8.4. Market Attractiveness Analysis By Region
9. North America Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
9.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
9.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
9.2.1. By Country
9.2.1.1. U.S.
9.2.1.2. Canada
9.2.2. By Type of indication
9.2.3. By Procedure of positioning of the device
9.2.4. By End user
9.3. Market Attractiveness Analysis
9.3.1. By Country
9.3.2. By Type of indication
9.3.3. By Procedure of positioning of the device
9.3.4. By End user
9.4. Key Takeaways
10. Latin America Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
10.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
10.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
10.2.1. By Country
10.2.1.1. Brazil
10.2.1.2. Mexico
10.2.1.3. Rest of Latin America
10.2.2. By Type of indication
10.2.3. By Procedure of positioning of the device
10.2.4. By End user
10.3. Market Attractiveness Analysis
10.3.1. By Country
10.3.2. By Type of indication
10.3.3. By Procedure of positioning of the device
10.3.4. By End user
10.4. Key Takeaways
11. Western Europe Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
11.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
11.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
11.2.1. By Country
11.2.1.1. Germany
11.2.1.2. U.K.
11.2.1.3. France
11.2.1.4. Spain
11.2.1.5. Italy
11.2.1.6. Rest of Western Europe
11.2.2. By Type of indication
11.2.3. By Procedure of positioning of the device
11.2.4. By End user
11.3. Market Attractiveness Analysis
11.3.1. By Country
11.3.2. By Type of indication
11.3.3. By Procedure of positioning of the device
11.3.4. By End user
11.4. Key Takeaways
12. Eastern Europe Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
12.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
12.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
12.2.1. By Country
12.2.1.1. Poland
12.2.1.2. Russia
12.2.1.3. Czech Republic
12.2.1.4. Romania
12.2.1.5. Rest of Eastern Europe
12.2.2. By Type of indication
12.2.3. By Procedure of positioning of the device
12.2.4. By End user
12.3. Market Attractiveness Analysis
12.3.1. By Country
12.3.2. By Type of indication
12.3.3. By Procedure of positioning of the device
12.3.4. By End user
12.4. Key Takeaways
13. South Asia and Pacific Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
13.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
13.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
13.2.1. By Country
13.2.1.1. India
13.2.1.2. Bangladesh
13.2.1.3. Australia
13.2.1.4. New Zealand
13.2.1.5. Rest of South Asia and Pacific
13.2.2. By Type of indication
13.2.3. By Procedure of positioning of the device
13.2.4. By End user
13.3. Market Attractiveness Analysis
13.3.1. By Country
13.3.2. By Type of indication
13.3.3. By Procedure of positioning of the device
13.3.4. By End user
13.4. Key Takeaways
14. East Asia Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
14.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
14.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
14.2.1. By Country
14.2.1.1. China
14.2.1.2. Japan
14.2.1.3. South Korea
14.2.2. By Type of indication
14.2.3. By Procedure of positioning of the device
14.2.4. By End user
14.3. Market Attractiveness Analysis
14.3.1. By Country
14.3.2. By Type of indication
14.3.3. By Procedure of positioning of the device
14.3.4. By End user
14.4. Key Takeaways
15. Middle East and Africa Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
15.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
15.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
15.2.1. By Country
15.2.1.1. GCC Countries
15.2.1.2. South Africa
15.2.1.3. Israel
15.2.1.4. Rest of MEA
15.2.2. By Type of indication
15.2.3. By Procedure of positioning of the device
15.2.4. By End user
15.3. Market Attractiveness Analysis
15.3.1. By Country
15.3.2. By Type of indication
15.3.3. By Procedure of positioning of the device
15.3.4. By End user
15.4. Key Takeaways
16. Key Countries Analysis
16.1. U.S.
16.1.1. Pricing Analysis
16.1.2. Market Share Analysis, 2022
16.1.2.1. By Type of indication
16.1.2.2. By Procedure of positioning of the device
16.1.2.3. By End user
16.2. Canada
16.2.1. Pricing Analysis
16.2.2. Market Share Analysis, 2022
16.2.2.1. By Type of indication
16.2.2.2. By Procedure of positioning of the device
16.2.2.3. By End user
16.3. Brazil
16.3.1. Pricing Analysis
16.3.2. Market Share Analysis, 2022
16.3.2.1. By Type of indication
16.3.2.2. By Procedure of positioning of the device
16.3.2.3. By End user
16.4. Mexico
16.4.1. Pricing Analysis
16.4.2. Market Share Analysis, 2022
16.4.2.1. By Type of indication
16.4.2.2. By Procedure of positioning of the device
16.4.2.3. By End user
16.5. Germany
16.5.1. Pricing Analysis
16.5.2. Market Share Analysis, 2022
16.5.2.1. By Type of indication
16.5.2.2. By Procedure of positioning of the device
16.5.2.3. By End user
16.6. U.K.
16.6.1. Pricing Analysis
16.6.2. Market Share Analysis, 2022
16.6.2.1. By Type of indication
16.6.2.2. By Procedure of positioning of the device
16.6.2.3. By End user
16.7. France
16.7.1. Pricing Analysis
16.7.2. Market Share Analysis, 2022
16.7.2.1. By Type of indication
16.7.2.2. By Procedure of positioning of the device
16.7.2.3. By End user
16.8. Spain
16.8.1. Pricing Analysis
16.8.2. Market Share Analysis, 2022
16.8.2.1. By Type of indication
16.8.2.2. By Procedure of positioning of the device
16.8.2.3. By End user
16.9. Italy
16.9.1. Pricing Analysis
16.9.2. Market Share Analysis, 2022
16.9.2.1. By Type of indication
16.9.2.2. By Procedure of positioning of the device
16.9.2.3. By End user
16.10. Poland
16.10.1. Pricing Analysis
16.10.2. Market Share Analysis, 2022
16.10.2.1. By Type of indication
16.10.2.2. By Procedure of positioning of the device
16.10.2.3. By End user
16.11. Russia
16.11.1. Pricing Analysis
16.11.2. Market Share Analysis, 2022
16.11.2.1. By Type of indication
16.11.2.2. By Procedure of positioning of the device
16.11.2.3. By End user
16.12. Czech Republic
16.12.1. Pricing Analysis
16.12.2. Market Share Analysis, 2022
16.12.2.1. By Type of indication
16.12.2.2. By Procedure of positioning of the device
16.12.2.3. By End user
16.13. Romania
16.13.1. Pricing Analysis
16.13.2. Market Share Analysis, 2022
16.13.2.1. By Type of indication
16.13.2.2. By Procedure of positioning of the device
16.13.2.3. By End user
16.14. India
16.14.1. Pricing Analysis
16.14.2. Market Share Analysis, 2022
16.14.2.1. By Type of indication
16.14.2.2. By Procedure of positioning of the device
16.14.2.3. By End user
16.15. Bangladesh
16.15.1. Pricing Analysis
16.15.2. Market Share Analysis, 2022
16.15.2.1. By Type of indication
16.15.2.2. By Procedure of positioning of the device
16.15.2.3. By End user
16.16. Australia
16.16.1. Pricing Analysis
16.16.2. Market Share Analysis, 2022
16.16.2.1. By Type of indication
16.16.2.2. By Procedure of positioning of the device
16.16.2.3. By End user
16.17. New Zealand
16.17.1. Pricing Analysis
16.17.2. Market Share Analysis, 2022
16.17.2.1. By Type of indication
16.17.2.2. By Procedure of positioning of the device
16.17.2.3. By End user
16.18. China
16.18.1. Pricing Analysis
16.18.2. Market Share Analysis, 2022
16.18.2.1. By Type of indication
16.18.2.2. By Procedure of positioning of the device
16.18.2.3. By End user
16.19. Japan
16.19.1. Pricing Analysis
16.19.2. Market Share Analysis, 2022
16.19.2.1. By Type of indication
16.19.2.2. By Procedure of positioning of the device
16.19.2.3. By End user
16.20. South Korea
16.20.1. Pricing Analysis
16.20.2. Market Share Analysis, 2022
16.20.2.1. By Type of indication
16.20.2.2. By Procedure of positioning of the device
16.20.2.3. By End user
16.21. GCC Countries
16.21.1. Pricing Analysis
16.21.2. Market Share Analysis, 2022
16.21.2.1. By Type of indication
16.21.2.2. By Procedure of positioning of the device
16.21.2.3. By End user
16.22. South Africa
16.22.1. Pricing Analysis
16.22.2. Market Share Analysis, 2022
16.22.2.1. By Type of indication
16.22.2.2. By Procedure of positioning of the device
16.22.2.3. By End user
16.23. Israel
16.23.1. Pricing Analysis
16.23.2. Market Share Analysis, 2022
16.23.2.1. By Type of indication
16.23.2.2. By Procedure of positioning of the device
16.23.2.3. By End user
17. Market Structure Analysis
17.1. Competition Dashboard
17.2. Competition Benchmarking
17.3. Market Share Analysis of Top Players
17.3.1. By Regional
17.3.2. By Type of indication
17.3.3. By Procedure of positioning of the device
17.3.4. By End user
18. Competition Analysis
18.1. Competition Deep Dive
18.1.1. Appriva Medical Inc.
18.1.1.1. Overview
18.1.1.2. Product Portfolio
18.1.1.3. Profitability by Market Segments
18.1.1.4. Sales Footprint
18.1.1.5. Strategy Overview
18.1.1.5.1. Marketing Strategy
18.1.2. Boston Scientific
18.1.2.1. Overview
18.1.2.2. Product Portfolio
18.1.2.3. Profitability by Market Segments
18.1.2.4. Sales Footprint
18.1.2.5. Strategy Overview
18.1.2.5.1. Marketing Strategy
18.1.3. Abbott
18.1.3.1. Overview
18.1.3.2. Product Portfolio
18.1.3.3. Profitability by Market Segments
18.1.3.4. Sales Footprint
18.1.3.5. Strategy Overview
18.1.3.5.1. Marketing Strategy
18.1.4. SentreHEART Inc
18.1.4.1. Overview
18.1.4.2. Product Portfolio
18.1.4.3. Profitability by Market Segments
18.1.4.4. Sales Footprint
18.1.4.5. Strategy Overview
18.1.4.5.1. Marketing Strategy
18.1.5. pfm medical ag.
18.1.5.1. Overview
18.1.5.2. Product Portfolio
18.1.5.3. Profitability by Market Segments
18.1.5.4. Sales Footprint
18.1.5.5. Strategy Overview
18.1.5.5.1. Marketing Strategy
18.1.6. Occlutech
18.1.6.1. Overview
18.1.6.2. Product Portfolio
18.1.6.3. Profitability by Market Segments
18.1.6.4. Sales Footprint
18.1.6.5. Strategy Overview
18.1.6.5.1. Marketing Strategy
18.1.7. W. L. Gore & Associates
18.1.7.1. Overview
18.1.7.2. Product Portfolio
18.1.7.3. Profitability by Market Segments
18.1.7.4. Sales Footprint
18.1.7.5. Strategy Overview
18.1.7.5.1. Marketing Strategy
18.1.8. Coherex Medical, Inc.
18.1.8.1. Overview
18.1.8.2. Product Portfolio
18.1.8.3. Profitability by Market Segments
18.1.8.4. Sales Footprint
18.1.8.5. Strategy Overview
18.1.8.5.1. Marketing Strategy
18.1.9. Cardia, Inc.
18.1.9.1. Overview
18.1.9.2. Product Portfolio
18.1.9.3. Profitability by Market Segments
18.1.9.4. Sales Footprint
18.1.9.5. Strategy Overview
18.1.9.5.1. Marketing Strategy
18.1.10. AtriCure, Inc.
18.1.10.1. Overview
18.1.10.2. Product Portfolio
18.1.10.3. Profitability by Market Segments
18.1.10.4. Sales Footprint
18.1.10.5. Strategy Overview
18.1.10.5.1. Marketing Strategy
19. Assumptions & Acronyms Used20. Research Methodology
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
List of Tables
Table 1: Global Value (US$ Million) Forecast by Region, 2018 to 2033
Table 2: Global Value (US$ Million) Forecast by Type of indication, 2018 to 2033
Table 3: Global Value (US$ Million) Forecast by Procedure of positioning of the device, 2018 to 2033
Table 4: Global Value (US$ Million) Forecast by End user , 2018 to 2033
Table 5: North America Value (US$ Million) Forecast by Country, 2018 to 2033
Table 6: North America Value (US$ Million) Forecast by Type of indication, 2018 to 2033
Table 7: North America Value (US$ Million) Forecast by Procedure of positioning of the device, 2018 to 2033
Table 8: North America Value (US$ Million) Forecast by End user , 2018 to 2033
Table 9: Latin America Value (US$ Million) Forecast by Country, 2018 to 2033
Table 10: Latin America Value (US$ Million) Forecast by Type of indication, 2018 to 2033
Table 11: Latin America Value (US$ Million) Forecast by Procedure of positioning of the device, 2018 to 2033
Table 12: Latin America Value (US$ Million) Forecast by End user , 2018 to 2033
Table 13: Western Europe Value (US$ Million) Forecast by Country, 2018 to 2033
Table 14: Western Europe Value (US$ Million) Forecast by Type of indication, 2018 to 2033
Table 15: Western Europe Value (US$ Million) Forecast by Procedure of positioning of the device, 2018 to 2033
Table 16: Western Europe Value (US$ Million) Forecast by End user , 2018 to 2033
Table 17: Eastern Europe Value (US$ Million) Forecast by Country, 2018 to 2033
Table 18: Eastern Europe Value (US$ Million) Forecast by Type of indication, 2018 to 2033
Table 19: Eastern Europe Value (US$ Million) Forecast by Procedure of positioning of the device, 2018 to 2033
Table 20: Eastern Europe Value (US$ Million) Forecast by End user , 2018 to 2033
Table 21: South Asia and Pacific Value (US$ Million) Forecast by Country, 2018 to 2033
Table 22: South Asia and Pacific Value (US$ Million) Forecast by Type of indication, 2018 to 2033
Table 23: South Asia and Pacific Value (US$ Million) Forecast by Procedure of positioning of the device, 2018 to 2033
Table 24: South Asia and Pacific Value (US$ Million) Forecast by End user , 2018 to 2033
Table 25: East Asia Value (US$ Million) Forecast by Country, 2018 to 2033
Table 26: East Asia Value (US$ Million) Forecast by Type of indication, 2018 to 2033
Table 27: East Asia Value (US$ Million) Forecast by Procedure of positioning of the device, 2018 to 2033
Table 28: East Asia Value (US$ Million) Forecast by End user , 2018 to 2033
Table 29: Middle East and Africa Value (US$ Million) Forecast by Country, 2018 to 2033
Table 30: Middle East and Africa Value (US$ Million) Forecast by Type of indication, 2018 to 2033
Table 31: Middle East and Africa Value (US$ Million) Forecast by Procedure of positioning of the device, 2018 to 2033
Table 32: Middle East and Africa Value (US$ Million) Forecast by End user , 2018 to 2033
Find your sweet spots for generating winning opportunities in this market.
List of Charts
Figure 1: Global Value (US$ Million) by Type of indication, 2023 to 2033
Figure 2: Global Value (US$ Million) by Procedure of positioning of the device, 2023 to 2033
Figure 3: Global Value (US$ Million) by End user , 2023 to 2033
Figure 4: Global Value (US$ Million) by Region, 2023 to 2033
Figure 5: Global Value (US$ Million) Analysis by Region, 2018 to 2033
Figure 6: Global Value Share (%) and BPS Analysis by Region, 2023 to 2033
Figure 7: Global Y-o-Y Growth (%) Projections by Region, 2023 to 2033
Figure 8: Global Value (US$ Million) Analysis by Type of indication, 2018 to 2033
Figure 9: Global Value Share (%) and BPS Analysis by Type of indication, 2023 to 2033
Figure 10: Global Y-o-Y Growth (%) Projections by Type of indication, 2023 to 2033
Figure 11: Global Value (US$ Million) Analysis by Procedure of positioning of the device, 2018 to 2033
Figure 12: Global Value Share (%) and BPS Analysis by Procedure of positioning of the device, 2023 to 2033
Figure 13: Global Y-o-Y Growth (%) Projections by Procedure of positioning of the device, 2023 to 2033
Figure 14: Global Value (US$ Million) Analysis by End user , 2018 to 2033
Figure 15: Global Value Share (%) and BPS Analysis by End user , 2023 to 2033
Figure 16: Global Y-o-Y Growth (%) Projections by End user , 2023 to 2033
Figure 17: Global Attractiveness by Type of indication, 2023 to 2033
Figure 18: Global Attractiveness by Procedure of positioning of the device, 2023 to 2033
Figure 19: Global Attractiveness by End user , 2023 to 2033
Figure 20: Global Attractiveness by Region, 2023 to 2033
Figure 21: North America Value (US$ Million) by Type of indication, 2023 to 2033
Figure 22: North America Value (US$ Million) by Procedure of positioning of the device, 2023 to 2033
Figure 23: North America Value (US$ Million) by End user , 2023 to 2033
Figure 24: North America Value (US$ Million) by Country, 2023 to 2033
Figure 25: North America Value (US$ Million) Analysis by Country, 2018 to 2033
Figure 26: North America Value Share (%) and BPS Analysis by Country, 2023 to 2033
Figure 27: North America Y-o-Y Growth (%) Projections by Country, 2023 to 2033
Figure 28: North America Value (US$ Million) Analysis by Type of indication, 2018 to 2033
Figure 29: North America Value Share (%) and BPS Analysis by Type of indication, 2023 to 2033
Figure 30: North America Y-o-Y Growth (%) Projections by Type of indication, 2023 to 2033
Figure 31: North America Value (US$ Million) Analysis by Procedure of positioning of the device, 2018 to 2033
Figure 32: North America Value Share (%) and BPS Analysis by Procedure of positioning of the device, 2023 to 2033
Figure 33: North America Y-o-Y Growth (%) Projections by Procedure of positioning of the device, 2023 to 2033
Figure 34: North America Value (US$ Million) Analysis by End user , 2018 to 2033
Figure 35: North America Value Share (%) and BPS Analysis by End user , 2023 to 2033
Figure 36: North America Y-o-Y Growth (%) Projections by End user , 2023 to 2033
Figure 37: North America Attractiveness by Type of indication, 2023 to 2033
Figure 38: North America Attractiveness by Procedure of positioning of the device, 2023 to 2033
Figure 39: North America Attractiveness by End user , 2023 to 2033
Figure 40: North America Attractiveness by Country, 2023 to 2033
Figure 41: Latin America Value (US$ Million) by Type of indication, 2023 to 2033
Figure 42: Latin America Value (US$ Million) by Procedure of positioning of the device, 2023 to 2033
Figure 43: Latin America Value (US$ Million) by End user , 2023 to 2033
Figure 44: Latin America Value (US$ Million) by Country, 2023 to 2033
Figure 45: Latin America Value (US$ Million) Analysis by Country, 2018 to 2033
Figure 46: Latin America Value Share (%) and BPS Analysis by Country, 2023 to 2033
Figure 47: Latin America Y-o-Y Growth (%) Projections by Country, 2023 to 2033
Figure 48: Latin America Value (US$ Million) Analysis by Type of indication, 2018 to 2033
Figure 49: Latin America Value Share (%) and BPS Analysis by Type of indication, 2023 to 2033
Figure 50: Latin America Y-o-Y Growth (%) Projections by Type of indication, 2023 to 2033
Figure 51: Latin America Value (US$ Million) Analysis by Procedure of positioning of the device, 2018 to 2033
Figure 52: Latin America Value Share (%) and BPS Analysis by Procedure of positioning of the device, 2023 to 2033
Figure 53: Latin America Y-o-Y Growth (%) Projections by Procedure of positioning of the device, 2023 to 2033
Figure 54: Latin America Value (US$ Million) Analysis by End user , 2018 to 2033
Figure 55: Latin America Value Share (%) and BPS Analysis by End user , 2023 to 2033
Figure 56: Latin America Y-o-Y Growth (%) Projections by End user , 2023 to 2033
Figure 57: Latin America Attractiveness by Type of indication, 2023 to 2033
Figure 58: Latin America Attractiveness by Procedure of positioning of the device, 2023 to 2033
Figure 59: Latin America Attractiveness by End user , 2023 to 2033
Figure 60: Latin America Attractiveness by Country, 2023 to 2033
Figure 61: Western Europe Value (US$ Million) by Type of indication, 2023 to 2033
Figure 62: Western Europe Value (US$ Million) by Procedure of positioning of the device, 2023 to 2033
Figure 63: Western Europe Value (US$ Million) by End user , 2023 to 2033
Figure 64: Western Europe Value (US$ Million) by Country, 2023 to 2033
Figure 65: Western Europe Value (US$ Million) Analysis by Country, 2018 to 2033
Figure 66: Western Europe Value Share (%) and BPS Analysis by Country, 2023 to 2033
Figure 67: Western Europe Y-o-Y Growth (%) Projections by Country, 2023 to 2033
Figure 68: Western Europe Value (US$ Million) Analysis by Type of indication, 2018 to 2033
Figure 69: Western Europe Value Share (%) and BPS Analysis by Type of indication, 2023 to 2033
Figure 70: Western Europe Y-o-Y Growth (%) Projections by Type of indication, 2023 to 2033
Figure 71: Western Europe Value (US$ Million) Analysis by Procedure of positioning of the device, 2018 to 2033
Figure 72: Western Europe Value Share (%) and BPS Analysis by Procedure of positioning of the device, 2023 to 2033
Figure 73: Western Europe Y-o-Y Growth (%) Projections by Procedure of positioning of the device, 2023 to 2033
Figure 74: Western Europe Value (US$ Million) Analysis by End user , 2018 to 2033
Figure 75: Western Europe Value Share (%) and BPS Analysis by End user , 2023 to 2033
Figure 76: Western Europe Y-o-Y Growth (%) Projections by End user , 2023 to 2033
Figure 77: Western Europe Attractiveness by Type of indication, 2023 to 2033
Figure 78: Western Europe Attractiveness by Procedure of positioning of the device, 2023 to 2033
Figure 79: Western Europe Attractiveness by End user , 2023 to 2033
Figure 80: Western Europe Attractiveness by Country, 2023 to 2033
Figure 81: Eastern Europe Value (US$ Million) by Type of indication, 2023 to 2033
Figure 82: Eastern Europe Value (US$ Million) by Procedure of positioning of the device, 2023 to 2033
Figure 83: Eastern Europe Value (US$ Million) by End user , 2023 to 2033
Figure 84: Eastern Europe Value (US$ Million) by Country, 2023 to 2033
Figure 85: Eastern Europe Value (US$ Million) Analysis by Country, 2018 to 2033
Figure 86: Eastern Europe Value Share (%) and BPS Analysis by Country, 2023 to 2033
Figure 87: Eastern Europe Y-o-Y Growth (%) Projections by Country, 2023 to 2033
Figure 88: Eastern Europe Value (US$ Million) Analysis by Type of indication, 2018 to 2033
Figure 89: Eastern Europe Value Share (%) and BPS Analysis by Type of indication, 2023 to 2033
Figure 90: Eastern Europe Y-o-Y Growth (%) Projections by Type of indication, 2023 to 2033
Figure 91: Eastern Europe Value (US$ Million) Analysis by Procedure of positioning of the device, 2018 to 2033
Figure 92: Eastern Europe Value Share (%) and BPS Analysis by Procedure of positioning of the device, 2023 to 2033
Figure 93: Eastern Europe Y-o-Y Growth (%) Projections by Procedure of positioning of the device, 2023 to 2033
Figure 94: Eastern Europe Value (US$ Million) Analysis by End user , 2018 to 2033
Figure 95: Eastern Europe Value Share (%) and BPS Analysis by End user , 2023 to 2033
Figure 96: Eastern Europe Y-o-Y Growth (%) Projections by End user , 2023 to 2033
Figure 97: Eastern Europe Attractiveness by Type of indication, 2023 to 2033
Figure 98: Eastern Europe Attractiveness by Procedure of positioning of the device, 2023 to 2033
Figure 99: Eastern Europe Attractiveness by End user , 2023 to 2033
Figure 100: Eastern Europe Attractiveness by Country, 2023 to 2033
Figure 101: South Asia and Pacific Value (US$ Million) by Type of indication, 2023 to 2033
Figure 102: South Asia and Pacific Value (US$ Million) by Procedure of positioning of the device, 2023 to 2033
Figure 103: South Asia and Pacific Value (US$ Million) by End user , 2023 to 2033
Figure 104: South Asia and Pacific Value (US$ Million) by Country, 2023 to 2033
Figure 105: South Asia and Pacific Value (US$ Million) Analysis by Country, 2018 to 2033
Figure 106: South Asia and Pacific Value Share (%) and BPS Analysis by Country, 2023 to 2033
Figure 107: South Asia and Pacific Y-o-Y Growth (%) Projections by Country, 2023 to 2033
Figure 108: South Asia and Pacific Value (US$ Million) Analysis by Type of indication, 2018 to 2033
Figure 109: South Asia and Pacific Value Share (%) and BPS Analysis by Type of indication, 2023 to 2033
Figure 110: South Asia and Pacific Y-o-Y Growth (%) Projections by Type of indication, 2023 to 2033
Figure 111: South Asia and Pacific Value (US$ Million) Analysis by Procedure of positioning of the device, 2018 to 2033
Figure 112: South Asia and Pacific Value Share (%) and BPS Analysis by Procedure of positioning of the device, 2023 to 2033
Figure 113: South Asia and Pacific Y-o-Y Growth (%) Projections by Procedure of positioning of the device, 2023 to 2033
Figure 114: South Asia and Pacific Value (US$ Million) Analysis by End user , 2018 to 2033
Figure 115: South Asia and Pacific Value Share (%) and BPS Analysis by End user , 2023 to 2033
Figure 116: South Asia and Pacific Y-o-Y Growth (%) Projections by End user , 2023 to 2033
Figure 117: South Asia and Pacific Attractiveness by Type of indication, 2023 to 2033
Figure 118: South Asia and Pacific Attractiveness by Procedure of positioning of the device, 2023 to 2033
Figure 119: South Asia and Pacific Attractiveness by End user , 2023 to 2033
Figure 120: South Asia and Pacific Attractiveness by Country, 2023 to 2033
Figure 121: East Asia Value (US$ Million) by Type of indication, 2023 to 2033
Figure 122: East Asia Value (US$ Million) by Procedure of positioning of the device, 2023 to 2033
Figure 123: East Asia Value (US$ Million) by End user , 2023 to 2033
Figure 124: East Asia Value (US$ Million) by Country, 2023 to 2033
Figure 125: East Asia Value (US$ Million) Analysis by Country, 2018 to 2033
Figure 126: East Asia Value Share (%) and BPS Analysis by Country, 2023 to 2033
Figure 127: East Asia Y-o-Y Growth (%) Projections by Country, 2023 to 2033
Figure 128: East Asia Value (US$ Million) Analysis by Type of indication, 2018 to 2033
Figure 129: East Asia Value Share (%) and BPS Analysis by Type of indication, 2023 to 2033
Figure 130: East Asia Y-o-Y Growth (%) Projections by Type of indication, 2023 to 2033
Figure 131: East Asia Value (US$ Million) Analysis by Procedure of positioning of the device, 2018 to 2033
Figure 132: East Asia Value Share (%) and BPS Analysis by Procedure of positioning of the device, 2023 to 2033
Figure 133: East Asia Y-o-Y Growth (%) Projections by Procedure of positioning of the device, 2023 to 2033
Figure 134: East Asia Value (US$ Million) Analysis by End user , 2018 to 2033
Figure 135: East Asia Value Share (%) and BPS Analysis by End user , 2023 to 2033
Figure 136: East Asia Y-o-Y Growth (%) Projections by End user , 2023 to 2033
Figure 137: East Asia Attractiveness by Type of indication, 2023 to 2033
Figure 138: East Asia Attractiveness by Procedure of positioning of the device, 2023 to 2033
Figure 139: East Asia Attractiveness by End user , 2023 to 2033
Figure 140: East Asia Attractiveness by Country, 2023 to 2033
Figure 141: Middle East and Africa Value (US$ Million) by Type of indication, 2023 to 2033
Figure 142: Middle East and Africa Value (US$ Million) by Procedure of positioning of the device, 2023 to 2033
Figure 143: Middle East and Africa Value (US$ Million) by End user , 2023 to 2033
Figure 144: Middle East and Africa Value (US$ Million) by Country, 2023 to 2033
Figure 145: Middle East and Africa Value (US$ Million) Analysis by Country, 2018 to 2033
Figure 146: Middle East and Africa Value Share (%) and BPS Analysis by Country, 2023 to 2033
Figure 147: Middle East and Africa Y-o-Y Growth (%) Projections by Country, 2023 to 2033
Figure 148: Middle East and Africa Value (US$ Million) Analysis by Type of indication, 2018 to 2033
Figure 149: Middle East and Africa Value Share (%) and BPS Analysis by Type of indication, 2023 to 2033
Figure 150: Middle East and Africa Y-o-Y Growth (%) Projections by Type of indication, 2023 to 2033
Figure 151: Middle East and Africa Value (US$ Million) Analysis by Procedure of positioning of the device, 2018 to 2033
Figure 152: Middle East and Africa Value Share (%) and BPS Analysis by Procedure of positioning of the device, 2023 to 2033
Figure 153: Middle East and Africa Y-o-Y Growth (%) Projections by Procedure of positioning of the device, 2023 to 2033
Figure 154: Middle East and Africa Value (US$ Million) Analysis by End user , 2018 to 2033
Figure 155: Middle East and Africa Value Share (%) and BPS Analysis by End user , 2023 to 2033
Figure 156: Middle East and Africa Y-o-Y Growth (%) Projections by End user , 2023 to 2033
Figure 157: Middle East and Africa Attractiveness by Type of indication, 2023 to 2033
Figure 158: Middle East and Africa Attractiveness by Procedure of positioning of the device, 2023 to 2033
Figure 159: Middle East and Africa Attractiveness by End user , 2023 to 2033
Figure 160: Middle East and Africa Attractiveness by Country, 2023 to 2033
